MANA THERAPEUTICS

mana-therapeutics-logo

Educating Immune Cells, Eliminating Cancer. Our team of scientists, physicians, and advocates are passionate about one thing: harnessing our immune cells to combat cancer - conferring lifelong immunity to the disease. Meet the team charged with immune cell education and cancer elimination.

#People #Financial #Website #More

MANA THERAPEUTICS

Industry:
Biotechnology

Founded:
2018-10-18

Address:
Arlington, Virginia, United States

Country:
United States

Website Url:
http://www.manatherapeutics.com

Total Employee:
1+

Status:
Active

Total Funding:
49.5 M USD

Technology used in webpage:
Viewport Meta Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Euro Organization Schema Typekit LocalBusiness Schema Squarespace



Current Advisors List

not_available_image

Drew Dennison Board Member @ Mana Therapeutics
Board_member
2021-01-01

Current Employees Featured

barbara-j-geiger_image

Barbara J. Geiger
Barbara J. Geiger Sr. Vice President Clinical Operations @ Mana Therapeutics
Sr. Vice President Clinical Operations
2020-12-01

martin-silverstein_image

Martin Silverstein
Martin Silverstein President and Chief Executive Officer @ Mana Therapeutics
President and Chief Executive Officer

Founder


marc-cohen_image

Marc Cohen

Investors List

j-w-partners_image

J&W Partners

J&W Partners investment in Series A - Mana Therapeutics

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Debt Financing - Mana Therapeutics

sk-securities_image

SK Securities

SK Securities investment in Series A - Mana Therapeutics

lifesci-venture-partners_image

LifeSci Venture Partners

LifeSci Venture Partners investment in Series A - Mana Therapeutics

cobro-ventures_image

Cobro Ventures

Cobro Ventures investment in Series A - Mana Therapeutics

lightchain_image

Lightchain

Lightchain investment in Series A - Mana Therapeutics

cobro-ventures_image

Cobro Ventures

Cobro Ventures investment in Seed Round - Mana Therapeutics

Official Site Inspections

http://www.manatherapeutics.com Semrush global rank: 5.66 M Semrush visits lastest month: 1.49 K

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Mana Therapeutics"

Mana Therapeutics - Crunchbase Company Profile & Funding

View contacts for Mana Therapeutics to access new leads and connect with decision-makers. Where is Mana Therapeutics's headquarters? Mana Therapeutics is located in Arlington, …See details»

Children’s National spin-out cell therapy company …

Feb 11, 2021 · MANA is a clinical stage company creating nonengineered, allogeneic and off-the-shelf cell therapies that target multiple cancer antigens.See details»

Mana Therapeutics - Craft

Mana Therapeutics is a biotechnology company that develops nonengineered, off-the-shelf allogeneic cell therapies targeting multiple cancer antigens.See details»

MANA Therapeutics - PitchBook

Developer of cell therapies designed to offer safer, more durable, and economically viable approaches to treating cancer. The company therapies include clinical cell immune therapies …See details»

MANA Therapeutics - Overview, News & Similar companies

May 10, 2021 · View MANA Therapeutics (www.manatherapeutics.com) location in Virginia, United States , revenue, industry and description. Find related and similar companies as well …See details»

Mana Therapeutics, Inc. - Drug pipelines, Patents, Clinical

Nov 1, 2024 · By utilizing the body's innate immune defense, MANA Therapeutics is innovating revolutionary cellular treatment options aiming at enhanced results for patients living with cancer.See details»

Mana Therapeutics, Inc. Company Profile - Dun & Bradstreet

Mana Therapeutics, Inc. Company Profile | Arlington, VA | Competitors, Financials & Contacts - Dun & BradstreetSee details»

MANA Therapeutics Announces Final Closing of Series …

Nov 30, 2021 · WALTHAM, Mass.-- ( BUSINESS WIRE )-- MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple cancer antigens, today...See details»

MANA Therapeutics Launches with $35 Million Series A …

Jan 8, 2021 · MANA is using its EDIFYâ„¢ platform to develop a pipeline of proprietary and partnered off-the-shelf cell therapies for cancer patients across a broad range of liquid and solid tumors, with an...See details»

MANA Therapeutics Announces Final Closing of Series A and …

Nov 30, 2021 · WALTHAM, Mass.-- ( BUSINESS WIRE )-- MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple …See details»

MANA Therapeutics Appoints Arthur Hurwitz as Chief …

May 10, 2021 · MANA Therapeutics’ EDIFYâ„¢ platform constitutes the next-generation cell therapy approach by leveraging natural immune system pathways to educate T-cells to target unique sets of antigens...See details»

Mana Therapeutics Raises $35M Series A Financing

Jan 8, 2021 · Mana Therapeutics, a Waltham, Mass.-based clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple cancer antigens, …See details»

Mana Therapeutics lands $35m Series A - venturecapitaljournal.com

Jan 8, 2021 · Mana Therapeutics, a creator of allogeneic cell therapies that target multiple cancer antigens, has raised $35 million in Series A financing. Cobro Ventures and Lightchain Capital …See details»

MANA Therapeutics Announces Final Closing of Series A and …

Nov 30, 2021 · MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple cancer antigens, today announced the final …See details»

Mana Therapeutics CEO and Key Executive Team | Craft.co

Mana Therapeutics's key executives include Barb Geiger and 1 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via …See details»

MANA Therapeutics Launches with $35 Million Series A Financing

MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple cancer antigens, today announce...See details»

President and Chief Executive Officer - Crunchbase

Martin Silverstein is a President and Chief Executive Officer at Mana Therapeutics, Inc. Martin attended Harvard Business School.See details»

MANA Therapeutics Appoints Arthur Hurwitz as Chief ... - BioSpace

May 10, 2021 · MANA Therapeutics is harnessing the natural immune system to develop broadly accessible, ready-to-use cellular therapies to improve outcomes for cancer patients.See details»

MANA Therapeutics Closes of Series A Financing | citybiz

Nov 30, 2021 · WALTHAM, Mass.–(BUSINESS WIRE)–MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple …See details»

Mana Therapeutics - VentureRadar

Website: http://www.manatherapeutics.com Develops off-the-shelf allogeneic cell therapies for treating diseases, utilizing innovative technology to create accessible, effective, and …See details»

linkstock.net © 2022. All rights reserved